keyword
https://read.qxmd.com/read/38712050/global-mapping-of-the-chlamydia-trachomatis-conventional-secreted-effector-host-interactome-reveals-cebn-interacts-with-nucleoporins-and-rae1-to-impede-stat1-nuclear-translocation
#41
Brianna Steiert, Shelby E Andersen, Paige N McCaslin, Cherilyn A Elwell, Robert Faris, Xavier Tijerina, Parker Smith, Quinn Eldridge, Brian S Imai, Justine V Arrington, Peter M Yau, Kathleen M Mirrashidi, Jeffrey R Johnson, Erik Verschueren, John Von Dollen, Gwendolyn M Jang, Nevan J Krogan, Joanne N Engel, Mary M Weber
Chlamydia trachomatis ( C.t .), the leading cause of bacterial sexually transmitted infections, employs a type III secretion system (T3SS) to translocate two classes of effectors, inclusion membrane proteins and conventional T3SS (cT3SS) effectors, into the host cell to counter host defense mechanisms. Here we employed three assays to directly evaluate secretion during infection, validating secretion for 23 cT3SS effectors. As bioinformatic analyses have been largely unrevealing, we conducted affinity purification-mass spectrometry to identify host targets and gain insights into the functions of these effectors, identifying high confidence interacting partners for 21 cT3SS effectors...
April 25, 2024: bioRxiv
https://read.qxmd.com/read/38711988/design-synthesis-molecular-docking-and-molecular-dynamic-studies-of-novel-quinazoline-derivatives-as-phosphodiesterase-7-inhibitors
#42
JOURNAL ARTICLE
Afaf A El-Malah, Magdy M Gineinah, Maan T Khayat, Anfal S Aljahdali, Marwa M Safar, Hadeel A Almazmumi, Roaa M Khinkar
Introduction: Phosphodiesterase 7 (PDE7) is a high-affinity cyclic AMP (cAMP)-specific PDE that is expressed in immune and proinflammatory cells. In this work, we explore the possibility that selective small molecule inhibitors of this enzyme family could provide a novel approach to alleviate the inflammation that is associated with many inflammatory diseases. Methods: A series of novel substituted 4-hydrazinoquinazoline derivatives and fused triazoloquinazolines were designed, synthesized, and evaluated in vitro for their PDE7A inhibition activities, in comparison with Theophylline, a non-selective PDE inhibitor, and BRL50481, a selective PDE7A inhibitor...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38711524/the-c1q-and-gc1qr-axis-as-a-novel-checkpoint-inhibitor-in-cancer
#43
REVIEW
Berhane Ghebrehiwet, Michal Zaniewski, Audrey Fernandez, Mathew DiGiovanni, Tiana N Reyes, Ping Ji, Anne G Savitt, Jennie L Williams, Markus A Seeliger, Ellinor I B Peerschke
Understanding at the molecular level of the cell biology of tumors has led to significant treatment advances in the past. Despite such advances however, development of therapy resistance and tumor recurrence are still unresolved major challenges. This therefore underscores the need to identify novel tumor targets and develop corresponding therapies to supplement existing biologic and cytotoxic approaches so that a deeper and more sustained treatment responses could be achieved. The complement system is emerging as a potential novel target for cancer therapy...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38711371/predicting-tcr-sequences-for-unseen-antigen-epitopes-using-structural-and-sequence-features
#44
JOURNAL ARTICLE
Hongchen Ji, Xiang-Xu Wang, Qiong Zhang, Chengkai Zhang, Hong-Mei Zhang
T-cell receptor (TCR) recognition of antigens is fundamental to the adaptive immune response. With the expansion of experimental techniques, a substantial database of matched TCR-antigen pairs has emerged, presenting opportunities for computational prediction models. However, accurately forecasting the binding affinities of unseen antigen-TCR pairs remains a major challenge. Here, we present convolutional-self-attention TCR (CATCR), a novel framework tailored to enhance the prediction of epitope and TCR interactions...
March 27, 2024: Briefings in Bioinformatics
https://read.qxmd.com/read/38709934/aire-mediates-tolerance-to-insulin-through-thymic-trimming-of-high-affinity-t-cell-clones
#45
JOURNAL ARTICLE
Jennifer A Smith, Benjamin T K Yuen, Whitney Purtha, Jared M Balolong, Jonah D Phipps, Frances Crawford, Jeffrey A Bluestone, John W Kappler, Mark S Anderson
Insulin is a central autoantigen in the pathogenesis of T1D, and thymic epithelial cell expression of insulin under the control of the Autoimmune Regulator ( Aire ) is thought to be a key component of maintaining tolerance to insulin. In spite of this general working model, direct detection of this thymic selection on insulin-specific T cells has been somewhat elusive. Here, we used a combination of highly sensitive T cell receptor transgenic models for detecting thymic selection and sorting and sequencing of Insulin-specific CD4+ T cells from Aire-deficient mice as a strategy to further define their selection...
May 14, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38708681/sr-bi-regulates-the-synergistic-mast-cell-response-by-modulating-the-plasma-membrane-associated-cholesterol-pool
#46
JOURNAL ARTICLE
Sandro Capellmann, Marlies Kauffmann, Michel Arock, Michael Huber
The high-affinity IgE receptor FcεRI is the mast cell (MC) receptor responsible for the involvement of MCs in IgE-associated allergic disorders. Activation of the FcεRI is achieved via crosslinking by multivalent antigen (Ag) recognized by IgE resulting in degranulation and proinflammatory cytokine production. In comparison to the T- and B-cell receptor complexes, for which several co-receptors orchestrating the initial signaling events have been described, information is scarce about FcεRI-associated proteins...
May 6, 2024: European Journal of Immunology
https://read.qxmd.com/read/38703588/psma-reactive-nb7-single-domain-antibody-fragment-a-potential-scaffold-for-developing-prostate-cancer-theranostics
#47
JOURNAL ARTICLE
Truc T Huynh, Yutian Feng, Rebecca Meshaw, Xiao-Guang Zhao, Lior Rosenfeld, Ganesan Vaidyanathan, Niv Papo, Michael R Zalutsky
INTRODUCTION: Single domain antibody fragments (sdAbs) are an appealing scaffold for radiopharmaceutical development due to their small size (~15 kDa), high solubility, high stability, and excellent tumor penetration. Previously, we developed NB7 sdAb, which has very high affinity for an epitope on PSMA that is different from those targeted by small molecule PSMA inhibitors. Herein, we evaluated NB7 after radioiodination using [*I]SGMIB (1,3,4-isomer) and iso-[*I]SGMIB (1,3,5-isomer), as well as their 211 At-labeled analogues...
April 25, 2024: Nuclear Medicine and Biology
https://read.qxmd.com/read/38700327/designing-a-smallpox-b-cell-and-t-cell-multi-epitope-subunit-vaccine-using-a-comprehensive-immunoinformatics-approach
#48
JOURNAL ARTICLE
Changqing Yu, Qi Wu, Jiuqing Xin, Qiujuan Yu, Zhixin Ma, Mengzhou Xue, Qingyuan Xu, Chunfu Zheng
UNLABELLED: Smallpox is a highly contagious human disease caused by the variola virus. Although the disease was eliminated in 1979 due to its highly contagious nature and historical pathogenicity, with a mortality rate of up to 30%, this virus is an important candidate for biological weapons. Currently, vaccines are the critical measures to prevent this virus infection and spread. In this study, we designed a peptide vaccine using immunoinformatics tools, which have the potential to activate human immunity against variola virus infection efficiently...
May 3, 2024: Microbiology Spectrum
https://read.qxmd.com/read/38697554/absence-of-atm-leads-to-altered-nk-cell-function-in-mice
#49
JOURNAL ARTICLE
Daniela Angela Covino, Maria Giovanna Desimio, Alessandro Giovinazzo, Bruna Sabino Pinho de Oliveira, Matilde Merolle, Daniela Marazziti, Manuela Pellegrini, Margherita Doria
Ataxia-telangiectasia (A-T) is a rare disorder caused by genetic defects of A-T mutated (ATM) kinase, a key regulator of stress response, and characterized by neurodegeneration, immunodeficiency, and high incidence of cancer. Here we investigated NK cells in a mouse model of A-T (Atm-/- ) showing that they are strongly impaired at killing tumor cells due to a block of early signaling events. On the other hand, in Atm-/- littermates with thymic lymphoma NK cell cytotoxicity is enhanced as compared with ATM-proficient mice, possibly via tumor-produced TNF-α...
April 30, 2024: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/38685808/improving-tamoxifen-performance-in-inducing-apoptosis-and-hepatoprotection-by-loading-on-a-dual-nanomagnetic-targeting-system
#50
JOURNAL ARTICLE
Yanfang Zhao, Wanbao Ding, Peixian Zhang, Lei Deng, Yi Long, Jiuqin Lu, Fereshteh Shiri, Mostafa Heidari Majd
BACKGROUND: Although tamoxifen (TMX) belongs to selective estrogen receptor modulators (SERMs) and selectively binds to estrogen receptors, it affects other estrogen-producing tissues due to passive diffusion and non-differentiation of normal and cancerous cells and leads to side effects. METHODS: The problems expressed about tamoxifen (TMX) encouraged us to design a new drug delivery system based on magnetic nanoparticles (MNPs) to simultaneously target two receptors on cancer cells through folic acid (FA) and hyaluronic acid (HA) groups...
April 29, 2024: Anti-cancer Agents in Medicinal Chemistry
https://read.qxmd.com/read/38685532/polymer-based-antibody-mimetics-ibodies-target-human-pd-l1-and-function-as-a-potent-immune-checkpoint-blocker
#51
JOURNAL ARTICLE
Mohammad Reza Zamani, Martin Hadzima, Kristyna Blazkova, Vladimír Šubr, Tereza Ormsby, Javier Celis-Gutierrez, Bernard Malissen, Libor Kostka, Tomáš Etrych, Pavel Šácha, Jan Konvalinka
Immune checkpoint blockade (ICB) using monoclonal antibodies against programmed cell death protein 1 (PD-1) or programmed death-ligand 1 (PD-L1) is the treatment of choice for cancer immunotherapy. However, low tissue permeability, immunogenicity, immune-related adverse effects, and high cost could be possibly improved using alternative approaches. On the other hand, synthetic low-molecular-weight (LMW) PD-1/PD-L1 blockers have failed to progress beyond in vitro studies, mostly due to low binding affinity or poor pharmacological characteristics resulting from their limited solubility and/or stability...
April 27, 2024: Journal of Biological Chemistry
https://read.qxmd.com/read/38685185/pharmacological-inhibition-of-hpk1-synergizes-with-pd-l1-blockade-to-provoke-antitumor-immunity-against-tumors-with-low-antigenicity
#52
JOURNAL ARTICLE
Genzui Setsu, Megumi Goto, Kentaro Ito, Tomoe Taira, Masaya Miyamoto, Tomohiro Watanabe, Saito Higuchi
Immune checkpoint inhibitors have significantly transformed the landscape of cancer therapy. Nevertheless, while these inhibitors are highly effective for certain patient groups, many do not benefit due to primary or acquired resistance. Specifically, these treatments often lack sufficient therapeutic efficacy against cancers with low antigenicity. Thus, the development of an effective strategy to overcome cancers with low antigenicity is imperative for advancing next-generation cancer immunotherapy. Here, we show that small molecule inhibitor of hematopoietic progenitor kinase 1 (HPK1) combined with programmed cell death ligand 1 (PD-L1) blockade can enhance T-cell response to tumor with low antigenicity...
April 24, 2024: Biochemical and Biophysical Research Communications
https://read.qxmd.com/read/38684865/identification-and-affinity-enhancement-of-t-cell-receptor-targeting-a-kras-g12v-cancer-neoantigen
#53
JOURNAL ARTICLE
Mengyu Zhang, Wei Xu, Lingjie Luo, Fenghui Guan, Xiangyao Wang, Pei Zhu, Jianhua Zhang, Xuyu Zhou, Feng Wang, Sheng Ye
Neoantigens derived from somatic mutations in Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS), the most frequently mutated oncogene, represent promising targets for cancer immunotherapy. Recent research highlights the potential role of human leukocyte antigen (HLA) allele A*11:01 in presenting these altered KRAS variants to the immune system. In this study, we successfully generate and identify murine T-cell receptors (TCRs) that specifically recognize KRAS8-16 G12V from three predicted high affinity peptides...
April 29, 2024: Communications Biology
https://read.qxmd.com/read/38683548/lipid-sulfoxide-polymers-as-potential-inhalable-drug-delivery-platforms-with-differential-albumin-binding-affinity
#54
JOURNAL ARTICLE
Gayathri R Ediriweera, Neville J Butcher, Ashok Kothapalli, Jiacheng Zhao, Joanne T Blanchfield, Christopher N Subasic, James L Grace, Changkui Fu, Xiao Tan, John F Quinn, David B Ascher, Michael R Whittaker, Andrew K Whittaker, Lisa M Kaminskas
Inhalable nanomedicines are increasingly being developed to optimise the pharmaceutical treatment of respiratory diseases. Large lipid-based nanosystems at the forefront of the inhalable nanomedicines development pipeline, though, have a number of limitations. The objective of this study was, therefore, to investigate the utility of novel small lipidated sulfoxide polymers based on poly(2-(methylsulfinyl)ethyl acrylate) (PMSEA) as inhalable drug delivery platforms with tuneable membrane permeability imparted by differential albumin binding kinetics...
April 29, 2024: Biomaterials Science
https://read.qxmd.com/read/38683349/development-and-first-in-human-study-of-psma-targeted-pet-tracers-with-improved-pharmacokinetic-properties
#55
JOURNAL ARTICLE
Haodong Hou, Yuan Pan, Yanzhi Wang, Yuze Ma, Xiaobing Niu, Suan Sun, Guihua Hou, Weijing Tao, Feng Gao
PURPOSE: A series of new 68 Ga-labeled tracers based on [68 Ga]Ga-PSMA-617 were developed to augment the tumor-to-kidney ratio and reduce the activity accumulation in bladder, ultimately minimize radiation toxicity to the urinary system. METHODS: We introduced quinoline group, phenylalanine and decanoic acid into different tracers to enhance their lipophilicity, strategically limiting their metabolic pathway through the urinary system. Their binding affinity onto LNCaP cells was determined through in vitro saturation assays and competition binding assays...
April 29, 2024: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/38683085/-ige-reactivity-of-a-recombinant-multi-epitope-protein-designed-from-allergens-of-interest-in-the-tropics-preliminary-findings
#56
JOURNAL ARTICLE
Luis Fang, Dalgys Martínez, Catherine Meza-Torres, Nicole Pereira-Sanandrés, Ana Moreno-Woo, Gloria Garavito, Eduardo Egea
OBJECTIVE: The objective of the present study was to design a multi-epitope protein from A. lumbricoides and APD allergens and to evaluate its IgE reactivity preliminarily. METHODS: Using computational tools, a molecule containing multiple "T" epitopes of allergens derived from A. lumbricoides and APD was designed " in silico " This multi-epitope protein (MP1) was expressed using an E. coli system and purified by affinity chromatography using Ni-NTA agarose. Anti-MP1 and anti-HDM extract IgE reactivity was evaluated by Dot-Blot and indirect ELISA from sera of HDM-allergic patients and non-allergic individuals from Barranquilla-Colombia...
February 1, 2024: Revista Alergia Mexico: Organo Oficial de la Sociedad Mexicana de Alergia e Inmunología, A.C
https://read.qxmd.com/read/38675833/design-of-vif-derived-peptide-inhibitors-with-anti-hiv-1-activity-by-interrupting-vif-cbf%C3%AE-interaction
#57
JOURNAL ARTICLE
Yanxin Gai, Sizhu Duan, Shiqi Wang, Kaifeng Liu, Xin Yu, Chumeng Yang, Guoqing Li, Yan Zhou, Bin Yu, Jiaxin Wu, Chu Wang, Xianghui Yu
One of the major functions of the accessory protein Vif of human immunodeficiency virus type 1 (HIV-1) is to induce the degradation of APOBEC3 (A3) family proteins by recruiting a Cullin5-ElonginB/C-CBFβ E3 ubiquitin ligase complex to facilitate viral replication. Therefore, the interactions between Vif and the E3 complex proteins are promising targets for the development of novel anti-HIV-1 drugs. Here, peptides are designed for the Vif-CBFβ interaction based on the sequences of Vif mutants with higher affinity for CBFβ screened by a yeast surface display platform...
March 22, 2024: Viruses
https://read.qxmd.com/read/38675586/evaluation-of-urtica-dioica-phytochemicals-against-therapeutic-targets-of-allergic-rhinitis-using-computational-studies
#58
JOURNAL ARTICLE
Erick Bahena Culhuac, Martiniano Bello
Allergic rhinitis (AR) is a prevalent inflammatory condition affecting millions globally, with current treatments often associated with significant side effects. To seek safer and more effective alternatives, natural sources like Urtica dioica (UD) are being explored. However, UD's mechanism of action remains unknown. Therefore, to elucidate it, we conducted an in silico evaluation of UD phytochemicals' effects on known therapeutic targets of allergic rhinitis: histamine receptor 1 (HR1), neurokinin 1 receptor (NK1R), cysteinyl leukotriene receptor 1 (CLR1), chemoattractant receptor-homologous molecule expressed on type 2 helper T cells (CRTH2), and bradykinin receptor type 2 (BK2R)...
April 12, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38675404/investigating-potential-cancer-therapeutics-insight-into-histone-deacetylases-hdacs-inhibitions
#59
JOURNAL ARTICLE
Basharat Ahmad, Aamir Saeed, Ahmed Al-Amery, Ismail Celik, Iraj Ahmed, Muhammad Yaseen, Imran Ahmad Khan, Dhurgham Al-Fahad, Mashooq Ahmad Bhat
Histone deacetylases (HDACs) are enzymes that remove acetyl groups from ɛ-amino of histone, and their involvement in the development and progression of cancer disorders makes them an interesting therapeutic target. This study seeks to discover new inhibitors that selectively inhibit HDAC enzymes which are linked to deadly disorders like T-cell lymphoma, childhood neuroblastoma, and colon cancer. MOE was used to dock libraries of ZINC database molecules within the catalytic active pocket of target HDACs...
March 29, 2024: Pharmaceuticals
https://read.qxmd.com/read/38675381/autopepvax-a-novel-machine-learning-based-program-for-vaccine-design-application-to-a-pan-cancer-vaccine-targeting-egfr-missense-mutations
#60
JOURNAL ARTICLE
Enrico Bautista, Young Hyun Jung, Manuela Jaramillo, Harrish Ganesh, Aryaan Varma, Kush Savsani, Sivanesan Dakshanamurthy
The current epitope selection methods for peptide vaccines often rely on epitope binding affinity predictions, prompting the need for the development of more sophisticated in silico methods to determine immunologically relevant epitopes. Here, we developed AutoPepVax to expedite and improve the in silico epitope selection for peptide vaccine design. AutoPepVax is a novel program that automatically identifies non-toxic and non-allergenic epitopes capable of inducing tumor-infiltrating lymphocytes by considering various epitope characteristics...
March 26, 2024: Pharmaceuticals
keyword
keyword
16362
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.